| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0891-5520(05)70128-8 |
| P698 | PubMed publication ID | 10987117 |
| P2093 | author name string | Kontoyiannis DP | |
| Bodey GP | |||
| Luna MA | |||
| Samuels BI | |||
| P2860 | cites work | Fungal infections complicating acute leukemia | Q70907925 |
| Diagnosis and therapeutic monitoring of invasive candidiasis by rapid enzymatic detection of serum D-arabinitol | Q71933435 | ||
| Fungal liver infection in marrow transplant recipients: prevalence at autopsy, predisposing factors, and clinical features | Q72344367 | ||
| Recombinant interferon-gamma enhances resistance to acute disseminated Candida albicans infection in mice | Q72842889 | ||
| Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications | Q73255365 | ||
| Diagnostic laparoscopy in patients with acute leukemia and suspected hepatic candidiasis | Q73834197 | ||
| Interferon gamma and granulocyte-macrophage colony-stimulating factor for the treatment of hepatosplenic candidosis in patients with acute leukemia | Q74141179 | ||
| Disseminated candidiasis in patients with acute leukemia: two diseases? | Q74802391 | ||
| [Treatment of hepatosplenic candidiasis with liposomal amphotericin B in a patient with acute leukemia; a case report of the experience of use of liposomal amphotericin B] | Q77056070 | ||
| Early detection of chronic disseminated Candida infection in leukemia patients with febrile neutropenia: value of computer-assisted serial ultrasound documentation | Q77368648 | ||
| Distribution and activity of amphotericin B in humans | Q93617796 | ||
| Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis. | Q30452906 | ||
| Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens | Q33854438 | ||
| Antifungal agents: chemotherapeutic targets and immunologic strategies | Q34400044 | ||
| Impact of the changing epidemiology of fungal infections in the 1990s | Q35375775 | ||
| Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review | Q35997161 | ||
| Hypersplenism due to fungal infection of spleen in a successfully treated patient with Hodgkin's disease | Q36722797 | ||
| Experimental basis for use of fluconazole for preventive or early treatment of disseminated candidiasis in granulocytopenic hosts | Q37918373 | ||
| Hepatosplenic candidiasis in children with cancer. Three cases in leukemic children and a literature review | Q37951562 | ||
| Chronic systemic candidiasis | Q38239718 | ||
| Hepatic candidiasis in cancer patients: the evolving picture of the syndrome | Q39626491 | ||
| Focal hepatic candidiasis: a distinct clinical variant of candidiasis in immunocompromised patients. | Q40195160 | ||
| The spectrum of hepatic candidiasis. | Q40342119 | ||
| A TH1-TH2-like switch in candidiasis: new perspectives for therapy. | Q40466988 | ||
| Hepatosplenic fungal disease: diagnostic accuracy and spectrum of appearances on MR imaging | Q40645257 | ||
| Use of abdominal computed tomography for identifying disseminated fungal infection in pediatric cancer patients | Q40686446 | ||
| Risk factors for hepatosplenic abscesses in patients with acute leukemia receiving empiric azole treatment. | Q40693151 | ||
| Ultrasound evaluation of hepatic and splenic microabscesses in the immunocompromised patient: sonographic patterns, differential diagnosis, and follow-up | Q40694756 | ||
| Hepatosplenic yeast infection in patients with acute leukemia: a diagnostic problem. | Q40700061 | ||
| Chronic systemic candidiasis in acute leukemia | Q40734095 | ||
| Hepatosplenic candidiasis: successful treatment with fluconazole | Q40746097 | ||
| Hepatic abscess in cancer patients. Characterization and management | Q40785090 | ||
| Fungal splenic abscess | Q40824174 | ||
| Fungal infection in acute leukemia | Q40917337 | ||
| Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients | Q40932334 | ||
| Hypersplenism due to disseminated candidiasis in a patient with acute leukemia | Q40938668 | ||
| The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside | Q41044970 | ||
| Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients | Q41108756 | ||
| Moniliasis in acute leukaemia | Q41284797 | ||
| International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections | Q41550505 | ||
| Detection of acute and treated lesions of hepatosplenic candidiasis: comparison of dynamic contrast-enhanced CT and MR imaging | Q42036419 | ||
| Experimental gastrointestinal and disseminated candidiasis in immunocompromised animals | Q43524410 | ||
| Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality | Q43662909 | ||
| Treatment of hepatosplenic candidiasis with liposomal-amphotericin B. | Q43673505 | ||
| Successful treatment of disseminated candidiasis resistant to amphotericin B by liposomal amphotericin B: a case report | Q44014532 | ||
| Successful treatment of hepatosplenic candidiasis through repeated cycles of chemotherapy and neutropenia | Q44117899 | ||
| Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group | Q44308537 | ||
| Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy | Q44822123 | ||
| Hepatosplenic fungal infection: CT and pathologic evaluation after treatment with liposomal amphotericin B. | Q45285564 | ||
| Increased serum concentrations of interleukin-10 in patients with hepatosplenic candidiasis | Q47713580 | ||
| High dose cytosine arabinoside is a major risk factor for the development of hepatosplenic candidiasis in patients with leukemia. | Q50906345 | ||
| Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. | Q53950594 | ||
| Hepatosplenic candidiasis: wheels within wheels. | Q54127835 | ||
| An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for hematological malignancy | Q58840045 | ||
| The Effect of Prophylactic Fluconazole on the Clinical Spectrum of Fungal Diseases in Bone Marrow Transplant Recipients with Special Attention to Hepatic Candidiasis: An Autopsy Study of 355 Patients | Q59512024 | ||
| Effects of preventive, early, and late antifungal chemotherapy with fluconazole in different granulocytopenic models of experimental disseminated candidiasis | Q68413711 | ||
| Evaluation of single-drug and combination antifungal therapy in an experimental model of candidiasis in rabbits with prolonged neutropenia | Q68438231 | ||
| Candida hepatitis. Histopathologic diagnosis | Q68499089 | ||
| Hepatic candidiasis: an increasing problem in immunocompromised patients | Q68766302 | ||
| Diagnosis and treatment of splenic fungal abscesses in the immune-suppressed patient | Q68876403 | ||
| Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen | Q70902917 | ||
| P433 | issue | 3 | |
| P921 | main subject | candidiasis | Q273510 |
| P304 | page(s) | 721-739 | |
| P577 | publication date | 2000-09-01 | |
| P1433 | published in | Infectious Disease Clinics of North America | Q15754797 |
| P1476 | title | Hepatosplenic candidiasis. A manifestation of chronic disseminated candidiasis | |
| P478 | volume | 14 |
| Q40265296 | 68-year-old man with neutropenic fever and upper extremity hematoma |
| Q34335250 | A clinical perspective for the management of invasive fungal infections: focus on IDSA guidelines. Infectious Diseases Society of America |
| Q28539165 | A new tool to quantify receptor recruitment to cell contact sites during host-pathogen interaction |
| Q37873552 | Antifungal treatment strategies in patients with haematological diseases or cancer: from prophylaxis to empirical, pre-emptive and targeted therapy |
| Q43190878 | Assessment of Aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis |
| Q34237335 | Canadian clinical practice guidelines for invasive candidiasis in adults |
| Q40472521 | Chronic Disseminated Candidiasis Complicated by Immune Reconstitution Inflammatory Syndrome in Child with Acute Lymphoblastic Leukemia. |
| Q91964412 | Chronic disseminated candidiasis manifesting as hepatosplenic abscesses among patients with hematological malignancies |
| Q34505582 | Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America |
| Q37624704 | Clinical aspects of invasive candidiasis: endocarditis and other localized infections |
| Q35038450 | Deeply invasive candidiasis |
| Q34490092 | Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? |
| Q40097081 | Hepatosplenic Candidiasis Detected by (18)F-FDG-PET/CT. |
| Q36862906 | Infectious diseases and the liver |
| Q34008698 | Invasive candidiasis stimulates hepatocyte and monocyte production of active transforming growth factor beta |
| Q53775218 | Letter to the editor-chronic disseminated candidiasis. |
| Q50019528 | Liver fungal infections: an overview of the etiology and epidemiology in patients affected or not affected by oncohematologic malignancies |
| Q35602480 | MR imaging in abdominal emergencies |
| Q35904821 | Management of invasive candidiasis in critically ill patients |
| Q37810281 | Managing fungal and viral infections in pediatric leukemia |
| Q37987555 | New insights into hepatosplenic candidosis, a manifestation of chronic disseminated candidosis. |
| Q45850524 | Pharmacokinetics and tissue distribution of amphotericin B following oral administration of three lipid-based formulations to rats |
| Q34768471 | Pharmacotherapy of Candida bloodstream infections: new treatment options, new era. |
| Q30833475 | Specific Human and Candida Cellular Interactions Lead to Controlled or Persistent Infection Outcomes during Granuloma-Like Formation. |
| Q44914755 | Successful treatment of chronic disseminated candidiasis with caspofungin and itraconazole in a patient with progressive acute leukemia and prolonged neutropenia |
| Q44606392 | Systemic antifungal agents |
| Q36661180 | Systemic illnesses unexpectedly presenting as acute appendicitis: case studies. |
| Q45061279 | Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome |
| Q82735018 | [Intraabdominal infection in inmunodepressed patients] |
Search more.